Back to Trades
LoPriore Vincent S
Executive ChairmanDirectorCIK 0001633927
Profile
- Filings
- 6
- Buy transactions
- 4
- Sell transactions
- 0
- Companies
- 2
- Active
- 2025–2026
Across 6 filings between 2025–2026, LoPriore Vincent S, Executive Chairman, Director, has disclosed $2.5M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward buying — $750.0K in buys and $0 in sells. The largest single open-market purchase on record is $500.0K in Hepion Pharmaceuticals, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Sep 14 | HEPA Hepion Pharmaceuticals, Inc. | LoPriore Vincent S | Executive Chairman, Director | Other | $750.0K |
| Aug 21 | HEPA Hepion Pharmaceuticals, Inc. | LoPriore Vincent S | Executive Chairman, Director | Award | $107.6K |
| Aug 12 | HEPA Hepion Pharmaceuticals, Inc. | LoPriore Vincent S | Executive Chairman, Director | Buy | $500.0K |
| Apr 27 | HEPA Hepion Pharmaceuticals, Inc. | LoPriore Vincent S | Executive Chairman, Director, 10% Owner | Buy | $250.0K |
| Nov 5 | THAR Tharimmune, Inc. | LoPriore Vincent S | Executive Chairman, Director, 10% Owner | Award | $276.8K |
| Aug 20 | THAR Tharimmune, Inc. | LoPriore Vincent S | Executive Chairman, Director, 10% Owner | Other | $0 |
6 filings